Abstract
Background
Ketogenic therapy is an adjunct therapy for drug-resistant epilepsy and is usually initiated while patients are hospitalized. Phoenix Children's has experience with safe and effective outpatient initiation of ketogenic therapy in infants 18 months of age and younger.
Methods
A retrospective chart review of 37 infants who initiated ketogenic therapy from 2011 to 2022 was performed.
Results
The median (range) age of patients was 10 (2-18) months. Ketogenic therapy reduced seizures by at least 50% in 23 of 37 patients (62%). Adverse effects were reported in 32 of 37 patients (86%), including constipation, vomiting, and acidosis. Of 32 patients who developed adverse effects, all were managed as outpatients, and 4 (12%) required hospitalization to manage additional adverse effects.
Conclusion
The results suggest that outpatient initiation of ketogenic therapy for infants ≤18 months of age was safe and efficacious in this cohort.
Get full access to this article
View all access options for this article.